Galderma has received regulatory approval in the U.S., EU, and Canada for a new, state-of-the-art syringe designed for its Restylane® NASHA® lidocaine portfolio. Developed alongside over 70 aesthetic practitioners, the syringe focuses on ergonomic precision to reduce hand strain while maintaining the high-quality results associated with the Restylane brand. Notably, the launch includes the industry’s first 100% recyclable paper packaging, reducing in-clinic waste by up to 30%. The new device is optimized to cover treatments for the face (including cheeks, jawline, and tear troughs) and hands.
Enhanced Precision and Ergonomics
The syringe was engineered to address the physical demands of aesthetic medicine. By collaborating with clinical experts, Galderma developed an innovative design featuring:
- Improved Comfort: A cushioned finger grip and thumb rest to minimize the risk of repetitive strain for practitioners.
- Better Control: Enhanced aspiration and operation, paired with the new Terumo K-Pack Enhance™ needle.
- Intuitive Navigation: Premium, color-coded packaging to help clinicians easily identify products within the NASHA® range.
The syringe is approved for use with Restylane Lyft™ Lidocaine, Restylane Eyelight™, and Restylane-L™ (also known as Classyc™ Lidocaine), ensuring that the most trusted hyaluronic acid (HA) fillers are now delivered with the industry’s most advanced hardware.
Leave a Reply